DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. $(BMY)$ slipped 1.90% to $63.61 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.32% to 7,728.20 and Dow Jones Industrial Average falling 0.34% to 53,791.85.

The stock's fall snapped a three-day winning streak.

Bristol Myers Squibb Co. closed 6.59% short of its 52-week high of $68.10, which the company achieved on August 3rd.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.77% to $259.80, Pfizer Inc. $(PFE)$ fell 1.59% to $26.62, and Abbott Laboratories $(ABT)$ rose 1.01% to $109.72.

Trading volume (9.3 M) remained 3.9 million below its 50-day average volume of 13.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.